This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Science Co., Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Jae Hee Hee Shin: Innovator in Insulin Conjugate Technology.
Introduction
Jae Hee Hee Shin is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of insulin conjugates. His innovative work aims to improve the efficacy and stability of insulin treatments for patients.
Latest Patents
Jae Hee Hee Shin holds a patent for an "Insulin conjugate using an immunoglobulin fragment." This invention provides an insulin conjugate that has improved in vivo duration and stability. The conjugate is prepared by covalently linking insulin with an immunoglobulin Fc region via a non-peptidyl polymer. This long-acting formulation maintains the in vivo activity of the peptide at a relatively high level and remarkably increases the serum half-life, thereby greatly improving drug compliance during insulin treatment. He has 1 patent to his name.
Career Highlights
Jae Hee Hee Shin is associated with Hanmi Science Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in enhancing the therapeutic options available for diabetes management.
Collaborations
He collaborates with notable colleagues, including Dae Seong Im and Se Chang Kwon, who contribute to his research endeavors and help drive innovation in the field.
Conclusion
Jae Hee Hee Shin's contributions to insulin conjugate technology represent a significant advancement in diabetes treatment. His innovative approach not only enhances the stability and duration of insulin but also improves patient compliance, marking a notable achievement in biotechnology.